Bitcoin Report: A Look at the First Tax Exempted Bitcoin Charity

The BitGive Foundation announced today that it has become the first nonprofit bitcoin organization to achieve 501(c)(3) status, meaning the Internal Revenue Service (IRS) officially recognizes it as a charitable organisation in the US. This means that any gains made by the foundation will not be taxed, thus directing more money to its supported causes.

BitGive executive director Connie Gallippi told that it is about more than just money, however, “It does give us legitimacy with the US government, which has been a huge struggle for bitcoin as far as businesses are concerned.”

BitGive is dedicated to improving the public health and environment worldwide by giving funds that it raises to various philanthropic organizations and projects. It accepts corporate and individual donations, and counts BitPay, Xapo, LibraTax and Roger Ver among its founding donors.

News on Bitcoins

Today the foundation also launches two new initiatives: the Founding Donors Campaign and a membership program for individuals. Each is open to donors worldwide.

The new campaign is aimed at one-shot donations from larger groups or companies to help get the foundation’s activity rolling, whereas the membership program is being offered to individuals on an annual basis to support the underlying operations of the organization. Furthermore, in the following year, the foundation plans to offer an annual component to corporations and larger donors.

Gallippi said that the organization’s long-term functionality is to have the equivalent of a multi-million-dollar investment trust, in bitcoin, from which it can give to causes and projects.

Bitcoin News Video

Watch this video for more “News on Bitcoin”.

Continue reading “Bitcoin Report: A Look at the First Tax Exempted Bitcoin Charity”

Biotech Stocks: Invest in Biotech, But at Your Own Risk

Fed Chair Janet Yellen testified before the US Senate Committee on Banking, Housing, and Urban Affairs. She presented the Fed’s semiannual Monetary Policy Report (MPR) to the Congress. In her prepared remarks, she stated that while valuation seems “stretched” in some areas of the bond market, equities “remain generally in line with historical norms.” Yet in the MPR, which bears her signature, the following observation … Continue reading Biotech Stocks: Invest in Biotech, But at Your Own Risk

The Rising Stock: Apple’s HealthKit Questioned but the Stock AAPL seems Strong

According to some doctors, Apple Inc (NASDAQ AAPL)’s new HealthKit app poses almost as many potential problems as it does benefits. An article in Forbes published on Thursday August 21st highlights that a number of medical authorities are now stepping up to the plate to explain HealthKit and elaborate on the pluses and minuses of this ground-breaking health care technology. The Apple HealthKit app poses … Continue reading The Rising Stock: Apple’s HealthKit Questioned but the Stock AAPL seems Strong

Stock in Focus: A Look at the Facebook (NASDAQ FB) Messenger App

Facebook (NASDAQ FB) Stock has looked upbeat in the recent past despite privacy fears. Introduction of the Messenger App, did not do Facebook any favours either. Change is inevitable, especially for mobile users like you and me. If you’re a Facebook (NASDAQ FB) user, then by now you must have noticed that you cannot send and receive messages from the Facebook app. Strangely, the social … Continue reading Stock in Focus: A Look at the Facebook (NASDAQ FB) Messenger App

Stock in Focus: Google (NASDAQ GOOG) App Among the Top Used Smartphone Apps

Google Inc (NASDAQ GOOG) app has a high number of smartphone users in the United States, according to a mobile app report by comScore. The report reveals that most of the time spent on mobile devices is absorbed by social networking, entertainment and messaging apps. Also just a few apps are regularly used, while rest of them are just ignored. Facebook’s app is comfortably sitting … Continue reading Stock in Focus: Google (NASDAQ GOOG) App Among the Top Used Smartphone Apps

Biotech stock market news

Biotech Stocks Highlights: A look at Last Week’s Performance

With second quarter earnings season coming to an end, focus in the biotech sector is back on pipeline and regulatory updates. Last week’s highlights included Achillion Pharmaceuticals, Inc.’s (ACHN) impressive interim data on its experimental hepatitis C virus (HCV) treatment, Gilead Sciences’ (GILD – Analyst Report) legal victory and Amgen’s (AMGN – Analyst Report) hit and miss on the clinical front. Achillion, which focuses on … Continue reading Biotech Stocks Highlights: A look at Last Week’s Performance